GPCR Therapeutics Expands Scientific Advisory Board

Seoul, South Korea, 29 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, today announced four appointments to its Scientific Advisory Board (SAB...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,United States ,Lisbon ,Lisboa ,Portugal ,Michigan ,Dominica ,Sutro Biopharma ,Omar Nadeem ,Michel Bouvier ,Jon Wigginton ,Robertj Lefkowitz ,Luisa Salter Cid ,Bristol Myers Squibb ,Linkedin ,University Of Lisbon ,National Cancer Institute ,Ross University ,Institute For Research ,Merck Co ,University Of Michigan ,University Of Massachusetts ,Cancer Research ,Therapeutics Inc ,Dana Farber Cancer Institute ,Checkmate Pharmaceuticals ,Macrogenics Inc ,Neurological Sciences ,Cullinan Oncology Inc ,University Of Miami ,Myeloma Cellular Therapies Program ,Duke University ,Scientific Advisory Board ,Scientific Advisory ,Dongseung Seen ,Molecular Medicine ,Nobel Laureate ,Pioneering Medicines ,Flagship Pioneering ,Gossamer Bio ,Vice President ,Medical Oncology ,Multiple Myeloma ,Clinical Director ,Dana Farber Cancer ,Senior Advisor ,Cullinan Oncology ,Chief Medical Officer ,Investigational Biologics Section ,San Francisco Bay Area ,